ALPA logo

ALPA Laboratories LTD

ALPA·NSE·
₹53.85▼ -2.11 (-3.77%)
Market Cap112.48 Cr
PE Ratio8.03
Volume30,544
Day High - Low57.00 - 50.61
52W High-Low93.85 - 46.10

Alpa Laboratories Ltd (ALPA): company summary

The company's annual revenue fell 3.8% year-over-year, while its latest quarter revenue rose 25.2% compared to the same quarter a year earlier.

Alpa Laboratories Ltd (ALPA) is a micro-cap Healthcare company valued at ₹112 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move
Alpa Laboratories Ltd last traded at ₹53.85, down 3.77% on the day.
Recent developments
2026-09-01: ALPA India highlighted senior pilots' attrition at Air India Group and called for an independent review. 2026-07-20: ALPA India urged the DGCA to suspend Dubai and Abu Dhabi-bound flights due to Middle-East tensions and offered technical support to the DGCA.
Financial performance
The company's annual revenue fell 3.8% year-over-year, while its latest quarter revenue rose 25.2% compared to the same quarter a year earlier. Annual net profit dropped 24.9%, but the latest quarter net profit fell 91.7% from the prior year's quarter. The net profit margin narrowed 4.0 percentage points to 14.2%, and return on equity remained at 8.1%.
Valuation multiples
The stock trades at 8.0 times earnings, a discount to the Healthcare median of 32.0, 0.73 times book value.
Things to watch
The company's latest quarter net profit fell 91.7% from the prior year's quarter. The net profit margin narrowed 4.0 percentage points to 14.2%. The stock is 36.9% below its 52-week high.
Where it stands
The company's latest quarter revenue rose 25.2% compared to the same quarter a year earlier, but net profit fell 91.7%. The stock is 36.9% below its 52-week high. The net profit margin narrowed 4.0 percentage points to 14.2%.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
5.4/10
Weak
Fair Value
Sign in to see
ROE
8.06%
Average
P/E
8.03x
Cheap
Debt / Equity
0.01
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day₹50.61
₹57.00
52W₹46.10
₹93.85
DocStoX take

Supported by valuation (8.7) and risk (8.3), but held back by momentum (0.2). Valuation looks strong at 8.7, but that is offset by momentum at 0.2. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.4
/10
Weak
Quality
Modest
ROE 8.1%
Valuation
Cheap
P/E 8.0×
Growth
Steady
Revenue +1.8% 5Y CAGR
Risk
Low risk
D/E 0.01
Momentum
Weak
16% of 52-week range

At a glance

Market Cap
₹112 Cr
52W High / Low
₹94 / ₹46
Dividend Yield
0.00%
Promoter Holding
57.19%
EPS (TTM)
₹6.71
Book Value
₹88.53

Key highlights

  • Low leverage — D/E 0.01
  • Profitable in all of the last 5 years
  • Undemanding at 8× earnings
  • Momentum is weak (0.2/10)
  • Revenue barely growing (2% a year)
4 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

ALPA LABORATORIES LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.